97 related articles for article (PubMed ID: 9864294)
1. Peripheral effects of opioids in a model of chronic intestinal inflammation in mice.
Puig MM; Pol O
J Pharmacol Exp Ther; 1998 Dec; 287(3):1068-75. PubMed ID: 9864294
[TBL] [Abstract][Full Text] [Related]
2. Intestinal inflammation enhances the inhibitory effects of opioids on intestinal permeability in mice.
Valle L; Pol O; Puig MM
J Pharmacol Exp Ther; 2001 Feb; 296(2):378-87. PubMed ID: 11160621
[TBL] [Abstract][Full Text] [Related]
3. Reversal of tolerance to the antitransit effects of morphine during acute intestinal inflammation in mice.
Pol O; Puig MM
Br J Pharmacol; 1997 Nov; 122(6):1216-22. PubMed ID: 9401789
[TBL] [Abstract][Full Text] [Related]
4. Diarrhea associated with intestinal inflammation increases the potency of mu and delta opioids on the inhibition of gastrointestinal transit in mice.
Pol O; Ferrer I; Puig MM
J Pharmacol Exp Ther; 1994 Jul; 270(1):386-91. PubMed ID: 8035336
[TBL] [Abstract][Full Text] [Related]
5. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
Jiménez N; Puig MM; Pol O
J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
[TBL] [Abstract][Full Text] [Related]
6. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
7. Peripheral effects of opioids in a model of intestinal inflammation in mice.
Pol O; Sanchez B; Puig MM
Pharmacology; 1996 Dec; 53(6):340-50. PubMed ID: 9032798
[TBL] [Abstract][Full Text] [Related]
8. The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice.
Pol O; Sasaki M; Jiménez N; Dawson VL; Dawson TM; Puig MM
Br J Pharmacol; 2005 Jul; 145(6):758-66. PubMed ID: 15852037
[TBL] [Abstract][Full Text] [Related]
9. Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit.
Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):165-9. PubMed ID: 7796321
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligodeoxynucleotides to mu- and delta-opioid receptor mRNA block the enhanced effects of opioids during intestinal inflammation.
Pol O; Valle L; Puig MM
Eur J Pharmacol; 2001 Sep; 428(1):127-36. PubMed ID: 11779029
[TBL] [Abstract][Full Text] [Related]
11. Use of irreversible antagonists to determine the relative efficacy of mu-opioids in a pigeon drug discrimination procedure: comparison of beta-funaltrexamine and clocinnamox.
Barrett AC; Smith ES; Picker MJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1061-70. PubMed ID: 12649297
[TBL] [Abstract][Full Text] [Related]
12. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
[TBL] [Abstract][Full Text] [Related]
13. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice.
Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ
Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969
[TBL] [Abstract][Full Text] [Related]
14. Obstructive cholestasis alters intestinal transit in mice: role of opioid system.
Ghaffari K; Savadkuhi ST; Honar H; Riazi K; Shafaroodi H; Moezi L; Ebrahimkhani MR; Tahmasebi MS; Dehpour AR
Life Sci; 2004 Dec; 76(4):397-406. PubMed ID: 15530502
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
16. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice.
Waxman AR; Arout C; Caldwell M; Dahan A; Kest B
Neurosci Lett; 2009 Oct; 462(1):68-72. PubMed ID: 19559072
[TBL] [Abstract][Full Text] [Related]
18. Effects of morphine and liposomal morphine in a model of intestinal inflammation in mice.
Pol O; Planas E; Puig MM
Pharmacology; 1996 Sep; 53(3):180-9. PubMed ID: 8931103
[TBL] [Abstract][Full Text] [Related]
19. Increase in diazepam binding inhibitor expression by sustained morphine exposure is mediated via mu-opioid receptors in primary cultures of mouse cerebral cortical neurons.
Shibasaki M; Katsura M; Torigoe F; Honda T; Sumimoto A; Tsujimura A; Ohkuma S
J Neurosci Res; 2007 Oct; 85(13):2971-80. PubMed ID: 17638297
[TBL] [Abstract][Full Text] [Related]
20. Novel calmodulin antagonist CGS 9343B inhibits secretory diarrhea.
Shook JE; Burks TF; Wasley JW; Norman JA
J Pharmacol Exp Ther; 1989 Oct; 251(1):247-52. PubMed ID: 2795459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
